Diabetes and Kidneys: Unraveling T2D's Silent Threat
Diabetes and Kidneys: Unraveling T2D's Silent Threat
Podcast Description
This 6-part podcast mini-series, organized and supported by Bayer, is intended for healthcare professionals practicing in the US. Our aim is to raise awareness of the importance of early diagnosis and appropriate management of chronic kidney disease (CKD) in patients with type 2 diabetes in order to slow progression of CKD and reduce the risk of premature cardiovascular morbidity and mortality.
Podcast Insights
Content Themes
The podcast focuses on chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) with episodes that cover topics such as early diagnosis, patient empowerment, management strategies, and healthcare system interventions. For example, Episode 1 discusses the importance of early screening and diagnosis, while Episode 4 emphasizes lifestyle modifications and nonpharmaceutical strategies for CKD management.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.